Related Experiment Video
Updated: Apr 27, 2026

Using Extraordinary Optical Transmission to Quantify Cardiac Biomarkers in Human Serum
Published on: December 13, 2017
Rapid homogeneous immunoassay for cardiac troponin I using switchable lanthanide luminescence
Henna Päkkilä1, Eeva Malmi1, Satu Lahtinen1
1Department of Biochemistry/Biotechnology, Tykistökatu 6A, 6th Floor, FI-20520 Turku, Finland.
Insights
This study introduces a novel homogeneous immunoassay using switchable lanthanide luminescence. The assay offers rapid kinetics and sensitive detection of cardiac troponin I, overcoming limitations of traditional homogeneous assays.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Biochemistry
Background:
- Homogeneous assays offer simplicity and speed but often lack the sensitivity of heterogeneous assays.
- Traditional homogeneous immunoassays struggle with compromised performance compared to their heterogeneous counterparts.
- Developing sensitive and rapid homogeneous assays remains a significant challenge in diagnostics.
Purpose of the Study:
- To develop a high-performance homogeneous immunoassay using switchable lanthanide luminescence.
- To improve assay sensitivity and kinetics by employing site-specifically labeled recombinant antibody fragments.
- To demonstrate the potential of switchable lanthanide luminescence for advanced immunoassay development.
Main Methods:
- Utilized switchable lanthanide luminescence for signal generation, dividing the chelate into non-luminescent moieties.
- Employed site-specifically labeled recombinant antibody fragments for specific binding to cardiac troponin I.
- Developed a self-assembly mechanism where analyte recognition brings label moieties together to form a luminescent complex.
Main Results:
- Achieved elimination of assay background through the switchable luminescence mechanism.
- Maximal signal-to-background ratios were obtained within 6 minutes, indicating rapid assay kinetics.
- The limit of detection for cardiac troponin I was 0.38 ng/mL (16 pM), comparable to heterogeneous assays.
Conclusions:
- This work presents the first application of switchable lanthanide luminescence in immunoassays.
- The developed homogeneous immunoassay demonstrates versatile potential for rapid and sensitive diagnostic applications.
- The technology offers a promising alternative for improving homogeneous assay performance.
Abstract:
Homogeneous assays are advantageous because of their simplicity and rapid kinetics but typically their performance is severely compromised compared to heterogeneous assay formats. Here, we report a homogeneous immunoassay utilizing switchable lanthanide luminescence for detection and site-specifically labeled recombinant antibody fragments as binders to improve the assay performance. Switchable lanthanide luminescence enabled elimination of assay background due to division of the luminescent lanthanide chelate into two non-luminescent label moieties. Simultaneous biomolecular recognition of model analyte cardiac troponin I by two antibody fragments brought the label moieties together and resulted in self-assembly of luminescent mixed chelate complex. The assay was very rapid as maximal signal-to-background ratios were achieved already after 6 min of incubation. Additionally, the limit of detection was 0.38 ng/mL (16 pM), which was comparable to the limit of detection for the heterogeneous reference assay based on the same binders (0.26 ng/mL or 11 pM). This is the first study to apply switchable lanthanide luminescence in immunoassays and demonstrates the versatile potential of the technology for rapid and sensitive homogeneous assays.
More Related Videos
10:12A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
07:12Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells
Published on: September 9, 2021